Application | Comment | Organism |
---|---|---|
medicine | fatty acid amide hydrolase is involved in many human diseases, particularly cancer, pain and inflammation as well as neurological, metabolic and cardiovascular disorders. Therefore, FAAH is an attractive target for the development of low-molecular-weight inhibitors as therapeutics, which requires robust assays that can be used for high-throughput screening of compound libraries. A highly sensitive fluorescence-based assay with the substrate N-(6-methoxypyridin-3-yl)decanamide is described | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-[(3R)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one | - |
Homo sapiens | |
3'-carbamoyl[1,1'-biphenyl]-3-yl cyclohexylcarbamate | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00843 | - |
N-(6-methoxypyridin-3-yl)decanamide | pH 8.0, 30°C | Homo sapiens | |
0.16 | - |
N-(6-methoxypyridin-3-yl)octanamide | pH 8.0, 30°C | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.00908 | - |
Vmax, substrate: N-(6-methoxypyridin-3-yl)decanamide, pH 8.0, 30°C | Homo sapiens |
0.0213 | - |
Vmax, substrate: N-(6-methoxypyridin-3-yl)octanamide, pH 8.0, 30°C | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-(4-nitrophenyl)decanamide + H2O | - |
Homo sapiens | ? | - |
? | |
N-(4-nitrophenyl)octanamide + H2O | - |
Homo sapiens | ? | - |
? | |
N-(6-methoxypyridin-3-yl)decanamide + H2O | - |
Homo sapiens | ? | - |
? | |
N-(6-methoxypyridin-3-yl)octanamide + H2O | - |
Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
FAAH | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000884 | - |
pH 8.0, 30°C, substrate: N-(6-methoxypyridin-3-yl)octanamide | Homo sapiens | 3'-carbamoyl[1,1'-biphenyl]-3-yl cyclohexylcarbamate | |
0.000112 | - |
pH 8.0, 30°C, substrate: N-(6-methoxypyridin-3-yl)decanamide | Homo sapiens | 3'-carbamoyl[1,1'-biphenyl]-3-yl cyclohexylcarbamate | |
0.00211 | - |
pH 8.0, 30°C, substrate: N-(6-methoxypyridin-3-yl)octanamide | Homo sapiens | 1-[(3R)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one | |
0.99146 | - |
pH 8.0, 30°C, substrate: N-(6-methoxypyridin-3-yl)decanamide | Homo sapiens | 1-[(3R)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one |
General Information | Comment | Organism |
---|---|---|
metabolism | the enzyme is involved in many human diseases, particularly cancer, pain and inflammation as well as neurological, metabolic and cardiovascular disorders | Homo sapiens |